These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9059833)

  • 21. The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet.
    Schulpis KH; Karakonstantakis T; Bartzeliotou A; Karikas GA; Papassotiriou I
    Clin Nutr; 2004 Jun; 23(3):401-7. PubMed ID: 15158304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between plasma lipid concentrations and HDL subclasses.
    Yang Y; Yan B; Fu M; Xu Y; Tian Y
    Clin Chim Acta; 2005 Apr; 354(1-2):49-58. PubMed ID: 15748599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An immunoblotting method for high-resolution isoelectric focusing of protein isoforms on immobilized pH gradients.
    Towbin H; Ozbey O; Zingel O
    Electrophoresis; 2001 Jun; 22(10):1887-93. PubMed ID: 11465484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rosiglitazone modifies HDL structure and increases HDL-apo AI synthesis and catabolic rates.
    Carreón-Torres E; Rendón-Sauer K; Monter-Garrido M; Toledo-Ibelles P; Gamboa R; Menjivar M; López-Marure R; Luc G; Fievet C; Cruz D; Vargas-Alarcón G; Pérez-Méndez O
    Clin Chim Acta; 2009 Mar; 401(1-2):37-41. PubMed ID: 19036342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age.
    Gazzaruso C; Garzaniti A; Buscaglia P; Bonetti G; Falcone C; Fratino P; Finardi G; Geroldi D
    J Am Coll Cardiol; 1999 Jan; 33(1):157-63. PubMed ID: 9935023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Multidirectional effects of exercise of various type and intensity on lipid transport system of blood in healthy subjects and patients with coronary heart disease].
    Aronov DM; Bubnov MG; Perova NV; Bondarenko IZ
    Ter Arkh; 2005; 77(9):43-9. PubMed ID: 16281489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new approach to quantitate carbohydrate-deficient transferrin isoforms in alcohol abusers: partial iron saturation in isoelectric focusing/immunoblotting and laser densitometry.
    Bean P; Peter JB
    Alcohol Clin Exp Res; 1993 Dec; 17(6):1163-70. PubMed ID: 8116825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of human bone alkaline phosphatase isoforms: comparison of isoelectric focusing and ion-exchange high-performance liquid chromatography.
    Sharp CA; Linder C; Magnusson P
    Clin Chim Acta; 2007 Apr; 379(1-2):105-12. PubMed ID: 17289010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase gene.
    Pérez-Méndez O; Duhal N; Lacroix B; Bonte JP; Fruchart JC; Luc G
    Clin Chim Acta; 2006 Jun; 368(1-2):149-54. PubMed ID: 16487502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice.
    Holvoet P; Danloy S; Deridder E; Lox M; Bernar H; Dhoest A; Collen D
    J Clin Invest; 1998 Jul; 102(2):379-85. PubMed ID: 9664079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of induced atherosclerosis in h-apo AI transgenic mice by overexpression of human apo AI in the aortic wall.
    Li H; Gu S; Cao X; Wang Z; She M
    Chin Med J (Engl); 2000 Jul; 113(7):657-61. PubMed ID: 11776042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.
    St-Pierre AC; Cantin B; Dagenais GR; Després JP; Lamarche B
    Am J Cardiol; 2006 Apr; 97(7):997-1001. PubMed ID: 16563904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporin A inhibits apolipoprotein AI gene expression.
    Zheng XL; Wong NC
    J Mol Endocrinol; 2006 Oct; 37(2):367-73. PubMed ID: 17032751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation.
    Emanuele E; Peros E; Minoretti P; D'Angelo A; Montagna L; Falcone C; Geroldi D
    Clin Chim Acta; 2004 Dec; 350(1-2):159-65. PubMed ID: 15530473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between MspI polymorphism of the APO AI gene and Type 2 diabetes mellitus.
    Morcillo S; Cardona F; Rojo-Martínez G; Esteva I; Ruíz-de-Adana MS; Tinahones F; Gómez-Zumaquero JM; Soriguer F
    Diabet Med; 2005 Jun; 22(6):782-8. PubMed ID: 15910632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 12-week worksite health promotion program reduces cardiovascular risk factors in male workers with the apolipoprotein E2 and apolipoprotein E3 genotypes, but not in apolipoprotein E4 genotype.
    Cho SW; Kang JY; Park YK; Paek YM; Choi TI
    Nutr Res; 2009 Aug; 29(8):542-50. PubMed ID: 19761888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein E phenotyping from plasma by isoelectric focusing and immunoblotting.
    Eto M; Watanabe K; Moriyama T; Makino I
    Tohoku J Exp Med; 1990 Apr; 160(4):301-9. PubMed ID: 2382259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pI-dependent isolation of antibody isoforms by semipreparative isoelectric focusing.
    Gangopadhyay A; Saravis CA; van den Abbeele AD; Kassis AI
    Q J Nucl Med; 1995 Jun; 39(2):129-33. PubMed ID: 8574807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of two new human apolipoprotein A-I variants: apolipoprotein A-I Tsushima (Trp-108-->Arg) and A-I Hita (Ala-95-->Asp).
    Araki K; Sasaki J; Matsunaga A; Takada Y; Moriyama K; Hidaka K; Arakawa K
    Biochim Biophys Acta; 1994 Oct; 1214(3):272-8. PubMed ID: 7918609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased proapolipoprotein A-I processing in liver disease: evidence for hepatic participation in proapolipoprotein A-I conversion.
    Isobe H; Sakai H; Satoh M; Sakamoto S; Koga S; Nawata H
    Clin Chim Acta; 1990 Aug; 189(3):303-11. PubMed ID: 2121392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.